Dual Action: Combines the benefits of GIP and GLP-1 receptor agonists in one medication, offering a unique approach to diabetes and weight management
Let them know what losing access would actually mean for you, whether that is unaffordable care, going without treatment, or turning to less safe options
FDA is aware of six adverse event reports associated with this lot, however none of them appear to be associated with the counterfeit product
An overactive bladder can cause urge incontinence, where sudden and intense urges to urinate lead to involuntary leakage
If you experience persistent vomiting, signs of dehydration, or are unable to maintain adequate nutrition despite using protein supplements, contact your GP promptly
The FDA issued warning letters in September 2025 related to GLP-1 distribution practices